RxDoctor Payments Data

Annie Arnold, NP

Family · Albany, GANPI 1972083905

Payments from drug & device makers

$686in general payments, 2019–2025

Across 30 payments — averaging $22.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$116
  • United Therapeutics Corporation$88
  • GSK$76
  • Johnson & Johnson$74
  • Mallinckrodt Hospital Products Inc.$68
  • AstraZeneca$57
  • plus $208 from 7 others

What the payments were for

  • Food & beverage$686100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$686 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$26,208
Medicare patients
155
Services billed
295

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter129$102,140
Breo ElliptaFluticasone/Vilanterol68$32,489
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$28,168
Spiriva RespimatTiotropium Bromide38$26,712
SymbicortBudesonide/Formoterol Fumarate57$17,672
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$7,675
Albuterol Sulfate HfaAlbuterol Sulfate253$6,211
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate30$4,836
Fluticasone-SalmeterolFluticasone Propion/Salmeterol29$3,636
Ventolin HfaAlbuterol Sulfate35$2,298
Wixela InhubFluticasone Propion/Salmeterol13$1,144
Azelastine Hcl13$548
Montelukast Sodium59$351
Fluticasone Propionate13$115
Prednisone28$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$76$142,304208 claims
AstraZenecaBreztri Aerosphere, Symbicort$57$45,84090 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,258 family providers in Georgia.

Other family in Albany

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →